Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

268 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Active, Not Recruiting

Real-life Treatment Outcomes of Ravulizumab in PNH

NCT06633536

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Research Site Bialystok, Poland
  • Research Site Brzozów, Poland
  • Research Site Bydgoszcz, Poland
  • Research Site Gdansk, Poland
View Trial Details
Active, Not Recruiting

Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria

NCT03157635

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Institut hematologie Centre Hayem CHU paris Saint-Louis Lariboisiere F Widal Hopital St Louis Paris, France
  • Uniklinik RWTH Aachen Aachen, Germany
  • Universitätsklinikum Essen Essen, Germany
  • Universitätsklinikum Ulm Ulm, Germany
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibition

NCT04654468

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • West China Hospital, Sichuan University Chengdu, China
  • Guangdong General Hospital Guangzhou, China
  • Institute of Hematology and Hospital of Blood Disease Tianjin, China
  • Tianjin Medical University General Hospital Tianjin, China
View Trial Details
Active, Not Recruiting

A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment

NCT05133531

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • The Oncology Institute of Hope & Innovation Whittier, California, United States
  • Centro de Estudos e Pesquisas em Hematologia e Oncologia Santo André, São Paulo, Brazil
  • A Beneficencia Portuguesa de Sao Paulo, BP Mirante São Paulo, Brazil
  • Casa de Saude Santa Marcelina São Paulo, Brazil
View all 68 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors

NCT04434092

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Organizacion Medica de Investigacion (OMI) Ciudad Autonoma Buenos Aires, Argentina
  • *X*CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia Santo André, São Paulo, Brazil
  • Beneficencia Portuguesa de Sao Paulo São Paulo, Brazil
  • Peking Union Medical College Hospital Beijing, China
View all 61 locations
View Trial Details

Related conditions